Break Down Barriers to Prescribing Buprenorphine for OUD

March 2025

You play a crucial role in ensuring patients have access to buprenorphine products (Suboxone, etc) for opioid use disorder (OUD).

We know buprenorphine is a first-line treatment for OUD.

But many patients who want or need treatment still can’t get it...despite changes to help increase access. For example, DEA-registered clinicians no longer need an “X” waiver to prescribe buprenorphine.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Acute Pain Don’t Jump to Suzetrigine for Acute Pain
Transdermal Patches Cut to the Chase About Whether It’s Okay to Cut Patches
Pneumonia Put a “CAP” on Rising Pneumonia Rates
Nutrition Share Nutrition Tips With Patients on a GLP-1 Agonist
Diabetes Stay Current on Med Recommendations for Diabetes
Substance Use Disorder Break Down Barriers to Prescribing Buprenorphine for OUD
Tuberculosis Sort Out Meds for Active Tuberculosis
NatMed Spotlight Emphasize Safety Concerns With Kratom

Break Down Barriers to Prescribing Buprenorphine for OUD

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Table of Contents